Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats

Research output: Contribution to conferenceAbstract

Abstract

Placental vascular physiology and function are critical for appropriate fetal growth and health outcomes in later life. Understanding how placental vasculature aligns with placental function, particularly in-vivo, may reveal underlying mechanisms that can inform interventions to improve long term fetal development outcomes. Classically, these research questions are addressed using invasive and terminal techniques such as histology and gene expression. However, in-vivo study of the placenta can permit repeated measures to serially investigate function and track development. Magnetic resonance imaging (MRI) is a noninvasive tool which can be used to study both placental morphology and function, as well as monitor development in-vivo.

This study aimed to establish in our laboratory an efficient and effective protocol of in-vivo MRI scans to assess placental function in rats. There are technical challenges in using MRI to assess placental function of rats in-vivo, e.g., motion, variable feto-placental position, image contrast, etc., which must be considered.

Pregnant Wistar rats were scanned serially at embryonic day (E) 15, 18, and 21 using 9.4 T MRI. Our established in-vivo MRI protocol includes: (i) T2 TurboRARE for fetal and placental anatomical imaging; (ii) an oxygen-challenge paradigm (air vs O2) obtaining 3D T1 and T2* relaxation maps for investigating tissue perfusion and blood oxygenation; (iii) bidirectional arterial spin labelling for feto-placental ordering; and (iv) dynamic contrast enhanced MRI for dynamic evaluation of placental perfusion (E21 only). After the E21 scan session, dams were euthanized for tissue collection and the number and ordering of feto-placental units confirmed.

Our preliminary data is congruent with the literature indicating that the relaxation mapping is sensitive to the oxygen-challenge paradigm. Research is on-going to validate the approach to study a maternal stressor model and how the MRI outcomes align with placental vascular structure.
Original languageEnglish
Pages159-160
Number of pages2
Publication statusPublished - Aug 2018
EventThe Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018 - Adelaide Convention Centre, Adelaide , Australia
Duration: 19 Aug 201822 Aug 2018
https://esa-srb.org.au/previous-meetings/program-2/

Conference

ConferenceThe Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018
Abbreviated titleESA-SRB 2018
CountryAustralia
CityAdelaide
Period19/08/1822/08/18
Internet address

Fingerprint

Blood Vessels
Magnetic Resonance Imaging
Fetal Development
Perfusion
Oxygen
Research
Placenta
Wistar Rats
Histology
Air
Mothers
Gene Expression
Health

Cite this

Tongpob, Y., Joos, A., & Feindel, K. (2018). Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats. 159-160. Abstract from The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, Adelaide , Australia.
Tongpob, Yutthapong ; Joos, Alexander ; Feindel, Kirk. / Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats. Abstract from The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, Adelaide , Australia.2 p.
@conference{87c3af85d3864eb28b45d122ff15f487,
title = "Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats",
abstract = "Placental vascular physiology and function are critical for appropriate fetal growth and health outcomes in later life. Understanding how placental vasculature aligns with placental function, particularly in-vivo, may reveal underlying mechanisms that can inform interventions to improve long term fetal development outcomes. Classically, these research questions are addressed using invasive and terminal techniques such as histology and gene expression. However, in-vivo study of the placenta can permit repeated measures to serially investigate function and track development. Magnetic resonance imaging (MRI) is a noninvasive tool which can be used to study both placental morphology and function, as well as monitor development in-vivo. This study aimed to establish in our laboratory an efficient and effective protocol of in-vivo MRI scans to assess placental function in rats. There are technical challenges in using MRI to assess placental function of rats in-vivo, e.g., motion, variable feto-placental position, image contrast, etc., which must be considered. Pregnant Wistar rats were scanned serially at embryonic day (E) 15, 18, and 21 using 9.4 T MRI. Our established in-vivo MRI protocol includes: (i) T2 TurboRARE for fetal and placental anatomical imaging; (ii) an oxygen-challenge paradigm (air vs O2) obtaining 3D T1 and T2* relaxation maps for investigating tissue perfusion and blood oxygenation; (iii) bidirectional arterial spin labelling for feto-placental ordering; and (iv) dynamic contrast enhanced MRI for dynamic evaluation of placental perfusion (E21 only). After the E21 scan session, dams were euthanized for tissue collection and the number and ordering of feto-placental units confirmed. Our preliminary data is congruent with the literature indicating that the relaxation mapping is sensitive to the oxygen-challenge paradigm. Research is on-going to validate the approach to study a maternal stressor model and how the MRI outcomes align with placental vascular structure.",
author = "Yutthapong Tongpob and Alexander Joos and Kirk Feindel",
year = "2018",
month = "8",
language = "English",
pages = "159--160",
note = "The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, ESA-SRB 2018 ; Conference date: 19-08-2018 Through 22-08-2018",
url = "https://esa-srb.org.au/previous-meetings/program-2/",

}

Tongpob, Y, Joos, A & Feindel, K 2018, 'Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats' The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, Adelaide , Australia, 19/08/18 - 22/08/18, pp. 159-160.

Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats. / Tongpob, Yutthapong; Joos, Alexander; Feindel, Kirk.

2018. 159-160 Abstract from The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, Adelaide , Australia.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats

AU - Tongpob, Yutthapong

AU - Joos, Alexander

AU - Feindel, Kirk

PY - 2018/8

Y1 - 2018/8

N2 - Placental vascular physiology and function are critical for appropriate fetal growth and health outcomes in later life. Understanding how placental vasculature aligns with placental function, particularly in-vivo, may reveal underlying mechanisms that can inform interventions to improve long term fetal development outcomes. Classically, these research questions are addressed using invasive and terminal techniques such as histology and gene expression. However, in-vivo study of the placenta can permit repeated measures to serially investigate function and track development. Magnetic resonance imaging (MRI) is a noninvasive tool which can be used to study both placental morphology and function, as well as monitor development in-vivo. This study aimed to establish in our laboratory an efficient and effective protocol of in-vivo MRI scans to assess placental function in rats. There are technical challenges in using MRI to assess placental function of rats in-vivo, e.g., motion, variable feto-placental position, image contrast, etc., which must be considered. Pregnant Wistar rats were scanned serially at embryonic day (E) 15, 18, and 21 using 9.4 T MRI. Our established in-vivo MRI protocol includes: (i) T2 TurboRARE for fetal and placental anatomical imaging; (ii) an oxygen-challenge paradigm (air vs O2) obtaining 3D T1 and T2* relaxation maps for investigating tissue perfusion and blood oxygenation; (iii) bidirectional arterial spin labelling for feto-placental ordering; and (iv) dynamic contrast enhanced MRI for dynamic evaluation of placental perfusion (E21 only). After the E21 scan session, dams were euthanized for tissue collection and the number and ordering of feto-placental units confirmed. Our preliminary data is congruent with the literature indicating that the relaxation mapping is sensitive to the oxygen-challenge paradigm. Research is on-going to validate the approach to study a maternal stressor model and how the MRI outcomes align with placental vascular structure.

AB - Placental vascular physiology and function are critical for appropriate fetal growth and health outcomes in later life. Understanding how placental vasculature aligns with placental function, particularly in-vivo, may reveal underlying mechanisms that can inform interventions to improve long term fetal development outcomes. Classically, these research questions are addressed using invasive and terminal techniques such as histology and gene expression. However, in-vivo study of the placenta can permit repeated measures to serially investigate function and track development. Magnetic resonance imaging (MRI) is a noninvasive tool which can be used to study both placental morphology and function, as well as monitor development in-vivo. This study aimed to establish in our laboratory an efficient and effective protocol of in-vivo MRI scans to assess placental function in rats. There are technical challenges in using MRI to assess placental function of rats in-vivo, e.g., motion, variable feto-placental position, image contrast, etc., which must be considered. Pregnant Wistar rats were scanned serially at embryonic day (E) 15, 18, and 21 using 9.4 T MRI. Our established in-vivo MRI protocol includes: (i) T2 TurboRARE for fetal and placental anatomical imaging; (ii) an oxygen-challenge paradigm (air vs O2) obtaining 3D T1 and T2* relaxation maps for investigating tissue perfusion and blood oxygenation; (iii) bidirectional arterial spin labelling for feto-placental ordering; and (iv) dynamic contrast enhanced MRI for dynamic evaluation of placental perfusion (E21 only). After the E21 scan session, dams were euthanized for tissue collection and the number and ordering of feto-placental units confirmed. Our preliminary data is congruent with the literature indicating that the relaxation mapping is sensitive to the oxygen-challenge paradigm. Research is on-going to validate the approach to study a maternal stressor model and how the MRI outcomes align with placental vascular structure.

M3 - Abstract

SP - 159

EP - 160

ER -

Tongpob Y, Joos A, Feindel K. Establishing an in-vivo magnetic resonance imaging (MRI) protocol for measurement of placental vascular function in rats. 2018. Abstract from The Joint Annual Scientific Meetings of the Endocrine Society of Australia (ESA) and the Society for Reproductive Biology (SRB) 2018, Adelaide , Australia.